SET-engineered T cells slowed tumor growth and prolonged survival in mice with human melanoma tumors (IMAGE)
Caption
SET-engineered T cells slowed tumor growth and prolonged survival in mice with human melanoma tumors, demonstrating the enhanced anti-tumor activity of the computationally designed receptor.
Credit
Prof. Cyrille Cohen, Bar-Ilan University
Usage Restrictions
None
License
Original content